Niowave Inc., a U.S.- based global leader in medical radioisotope production, announced the expansion of its existing supply agreement with AstraZeneca, a global biopharmaceutical company, to a 10-year commitment to deliver Actinium-225 (Ac-225), following AstraZeneca's decision to exercise its option to increase capa…
Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, announced a multi-year, global strategic collaboration and license agreement with Bristol Myers Squibb to discover and develop next-generation multi-specific antibodi…
Pixelgen Technologies, Inc. and MDxK (Molecular Diagnostics Korea) Inc., part of DKSH Business Unit Technology, a leader in market expansion services, announced a distribution agreement to bring Pixelgen's Proxiome Kit to life sciences researchers in South Korea. The agreement further expands Pixelgen's growth in the …
Sandoz , the global leader in affordable medicines, announced the completion of the acquisition of Just-Evotec Biologics EU SAS (JEB SAS) from Evotec SE. The deal includes the Toulouse development and manufacturing site and an indefinite licence to cutting-edge continuous-manufacturing technology for biosimilars.This …
Novo Nordisk and Akero Therapeutics Inc. announced that Novo Nordisk’s acquisition of Akero, has been completed. With the completion of the transaction, Novo Nordisk has acquired all outstanding shares of common stock and common stock equivalents of Akero for 54 USD per share in cash (or aggregated value of 4.7 billi…
Fosun Pharma announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Limited., Shanghai Fosun Pharmaceutical Industrial Development Company Limited, and Pfizer Inc. have entered into an exclusive collaboration and license agreement. Under this agreement, Yao Pharma grants Pfizer an exclusive worldwide l…
Microsize, a leading CDMO specializing in particle size reduction and control technologies, announced it has signed an agreement to acquire MicroMacinazione (Mic Mac), a dedicated micronization facility in Monteggio, Switzerland, from Lonza. The agreement represents Microsize’s second acquisition from Lonza, followi…
SCTbio, a leading European CDMO specializing in GMP manufacturing for cell-based products, and Fortrea, a leading global contract research organization (CRO), announced a strategic collaboration agreement between the two companies. This partnership aims to streamline development, accelerate timelines, and bring advanc…
Innovent Biologics announced that the global strategic collaboration with Takeda has closed and become effective following the satisfaction of all closing conditions. The collaboration, initially announced on October 22, 2025, aims to accelerate the global development and commercialization of Innovent's next-generatio…
Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”). This acquisition brings an early-stage combination vaccine candidate for respiratory syncytial virus (RSV) and human metapneumovirus (HMPV), both respiratory viruses, and expands the capabilities in vaccine design and development with Vice…
Page 23 of 39